Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer

Genes Chromosomes and Cancer

Volumn 24, Issue 3, 1999, Pages 175-182

  Li, Chunde ^a   Berx, Geert ^b   Larsson, Catharina ^a   Auer, Gert ^a   Aspenblad, Ulla ^a   Pan, Yi ^a   Sundelin, Birgitta ^a   Ekman, Peter ^a   Nordenskjöld, Magnus ^a   Van Roy, Frans ^b   Bergerheim, Ulf S R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; NERVE CELL ADHESION MOLECULE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL ADHESION; CHROMOSOME 16Q; CHROMOSOME DELETION; DISEASE ASSOCIATION; DNA DETERMINATION; EXON; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BRAIN NEOPLASMS; CADHERINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; DNA MUTATIONAL ANALYSIS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0032928520     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199903)24:3<175::AID-GCC1>3.0.CO;2-H     Document Type: Article

References (27)

1. Bergerheim USR, Kunimi K, Collins VP, Ekman P. 1991. Deletion mapping of chromosomes 8, 10, and 16 in human prostate carcinoma. Genes Chromosomes Cancer 3:215-220.
2. Berx G, Stass K, van Hengle J, Molemans F, Bussmankers MJG, van Bokhoven A, van Roy F. 1995a. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26:281-289.
3. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijiver M, Cornelisse C, van Roy F. 1995b. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115.
4. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. 1996. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
5. Berx G, Nollet F, Strumane K, van Roy F. 1997. An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene. Hum Mutat 9:567-574.
6. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Issac WB. 1990. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
7. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. 1994. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11:153-162.
8. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH. 1995. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254.
9. Dib C, Fauré S, Samson D, Drouot A, Vignal A, Milasseau S, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
10. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P. 1997. Loss of heterozygosity at 16q24.1-24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer, Cancer Res 57:3356-3359.
11. Gleason DF. 1977. Histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum M, editor. Urologic pathology. Philadelphia: Lea & Febiger, p 171-198.
12. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB. 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199.
13. Gumbiner B, Stevenson B, Grimaldi A. 1988. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575-1587.
14. Jewitt HJ. 1975. The present status of radical prostatectomy for stage A and B prostate cancer. Urol Clin North Am 2:105.
15. Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P. 1995. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14:267-276.
16. Koyama K, Emi M, Nakamura Y. 1993. The cell adhesion regulator gene. Tag1 and insertion/deletion polymorphisms, and regional assignment to the peritelomeric region of 16q by linkage analysis. Genomics 16:264-265.
17. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R. 1997. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res 57:1058-1062.
18. Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad A, Sundelin B, Liu Y, Ekman P. Auer G, Bergerheim USR. 1998. Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene 16:481-487.
19. Mostofi FK, Sesterhenn I, Sobin LH. 1980. Histological typing of prostate tumors. In International histological classification of tumors, vol. 22. Geneva: World Health Organization.
20. Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. 1989. v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci USA 86:7711-7715.
21. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tomé P, Aggarwal E, Bajorek E, Bentolila S, Birren B, Butler A, Castle AB, Chiannikulchai N, Chu A, Clee C, Cowles S, Day PJR, Diblin T, Drouot N, Dunham I, Duprat S, East C, Edwards C, Fan J-B, Fang N, Fizames C, Garrett C, Green L, Hadley D, Harris M, Harrison P, Brady S, Hicks A, Holloway E, Hui L, Hussain S, Louis-Dit-Sully C, Ma J, MacGilvery A, Mader C, Maratukulam A, Matise TC, McKusick KB, Morissette J, Mungall A, Muselet D, Nusbaum HC, Page DC, Peck A, Perkins S, Pircy F, Qin F, Quackenbush J, Ranby S, Reif T, Rosen S, Sandars C, She X, Silva J, Slonim DK, Soderlund C, Sun W-L, Tabar P, Thangarajah T, Vega-Czarny N, Vollrath D, Voytichy S, Wilmer T, Wu X, Adams MD, Auffray C, Walter NAR, Brandon R, Dehajia A, Goodfellow FN, Houlgatte R, Hudson JJR, Ide SE, Iorio KR, Lee WY, Seki N, Nagase T, Ishikawa K, Nomura N, Phillips C, Polymeropoulos MH, Sandusky M, Schmitt K, Berry R, Swanson K, Torres R, Venter JC, Sikela JM, Beckmann JS, Weissenbach J, Myers RM, Cox DR, James MR, Bentley D, Deloukas P, Lander ES, Hudson TJ. 1996. A gene map of the human genome. Science 274:540-546.
22. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraichi T, Yatani R, Shimazaki J. 1996. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 17:225-233.
23. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. 1992. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109.
24. Umbas R, Isaacs WB, Bringier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, Debruyne FMJ, Schalken JA. 1994. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929-3933.
25. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP. 1995. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
26. Whitmore WF Jr. 1956. Hormone therapy in prostate cancer. Am J Med 21:697.
27. Yoshida MC, Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. 1991. Localization of the human MAF protooncogene on chromosome 16 bands q22-23. Cytogenet Cell Genet 58:2003.